EverymonthPertuzumab2yearsLoperamideprophylaxisOlaparibLVEFmonitoringTaxanesIntermediate(11-25)10yearsChemoendocrinetherapyRadiationtherapyAbemaciclibAromataseinhibitorsCapecitabineAnthracyclinesTC (docetaxel /cyclophosphamide)TamoxifenExemestaneTNBCVenlafaxine1yearPembrolizumabPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)TDM-1(Ado-trastuzumabemtansine)EverymonthPertuzumab2yearsLoperamideprophylaxisOlaparibLVEFmonitoringTaxanesIntermediate(11-25)10yearsChemoendocrinetherapyRadiationtherapyAbemaciclibAromataseinhibitorsCapecitabineAnthracyclinesTC (docetaxel /cyclophosphamide)TamoxifenExemestaneTNBCVenlafaxine1yearPembrolizumabPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)TDM-1(Ado-trastuzumabemtansine)

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Every month
  2. Pertuzumab
  3. 2 years
  4. Loperamide prophylaxis
  5. Olaparib
  6. LVEF monitoring
  7. Taxanes
  8. Intermediate (11-25)
  9. 10 years
  10. Chemoendocrine therapy
  11. Radiation therapy
  12. Abemaciclib
  13. Aromatase inhibitors
  14. Capecitabine
  15. Anthracyclines
  16. TC (docetaxel / cyclophosphamide)
  17. Tamoxifen
  18. Exemestane
  19. TNBC
  20. Venlafaxine
  21. 1 year
  22. Pembrolizumab
  23. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  24. TDM-1 (Ado-trastuzumab emtansine)